Lewis Cirne - Jan 3, 2022 Form 4 Insider Report for NEW RELIC, INC. (NEWR)

Signature
Lewis Cirne, by /s/ Hannah E. Fleek, Attorney-in-Fact
Stock symbol
NEWR
Transactions as of
Jan 3, 2022
Transactions value $
-$4,816,533
Form type
4
Date filed
1/4/2022, 03:58 PM
Previous filing
Dec 27, 2021
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEWR Common Stock Options Exercise $508K +30K $16.93* 30K Jan 3, 2022 Direct
transaction NEWR Common Stock Sale -$1.02M -9.68K -32.28% $105.71 20.3K Jan 3, 2022 Direct F1, F2
transaction NEWR Common Stock Sale -$1.55M -14.5K -71.45% $106.56 5.8K Jan 3, 2022 Direct F1, F3
transaction NEWR Common Stock Sale -$558K -5.2K -89.66% $107.40 600 Jan 3, 2022 Direct F1, F4
transaction NEWR Common Stock Sale -$32.6K -300 -50% $108.59 300 Jan 3, 2022 Direct F1, F5
transaction NEWR Common Stock Sale -$33K -300 -100% $110.04 0 Jan 3, 2022 Direct F1, F6
transaction NEWR Common Stock Sale -$676K -6.4K -0.12% $105.71 5.48M Jan 3, 2022 By Trust F1, F2, F7
transaction NEWR Common Stock Sale -$1.04M -9.8K -0.18% $106.58 5.47M Jan 3, 2022 By Trust F1, F7, F8
transaction NEWR Common Stock Sale -$365K -3.4K -0.06% $107.38 5.47M Jan 3, 2022 By Trust F1, F7, F9
transaction NEWR Common Stock Sale -$21.7K -200 0% $108.55 5.47M Jan 3, 2022 By Trust F1, F7, F10
transaction NEWR Common Stock Sale -$22K -200 0% $110.06 5.47M Jan 3, 2022 By Trust F1, F6, F7
holding NEWR Common Stock 274K Jan 3, 2022 By Trust F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEWR Stock Option (Right to Buy) Options Exercise $0 -30K -7.79% $0.00 355K Jan 3, 2022 Common Stock 30K $16.93 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 plan.
F2 The shares were sold at prices ranging from $105.10 to $106.095. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The shares were sold at prices ranging from $106.10 to $107.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The shares were sold at prices ranging from $107.12 to $108.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 The shares were sold at prices ranging from $108.24 to $109.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6 The shares were sold at prices ranging from $110.01 to $110.11. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7 Shares are held directly by Lewis Cirne and Kirsten L. Vliet, as Trustees of the Cirne Family Revocable Trust UAD March 20, 2012.
F8 The shares were sold at prices ranging from $106.12 to $107.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F9 The shares were sold at prices ranging from $107.13 to $107.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F10 The shares were sold at prices ranging from $108.25 to $108.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F11 The shares are held directly by J.P. Morgan Trust Company of Delaware, as Trustee of the Cirne Family 2012 Irrevocable Trust.
F12 Fully vested and exercisable.